Form 4/A for COSM Cosmos Health Inc.
Accepted 2023-01-27 00:00:00 ET · period of report 2022-12-19 · accession 0001477932-23-000574 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2023-01-27 | 2022-12-19 | COSM | Siokas Grigorios | CEO, Dir, 10% | P - Purchase | $11.50 | +260.9K | 1.13M | +30% | +$3.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $.001 par value | 2022-12-19 | P | A | 260,870 | $11.50 | 1,130,774 | D | — | — | (F1) These shares were purchased by Mr. Siokas in a registered direct offering pursuant to the Company's "shelf" registration statement on Form S-3 (No. 333-267550) declared effective by the SEC on December 15, 2022. (F2) All share and per share amounts reflect a 1 for 25 reverse stock split effected on December 15, 2022 with the Secretary of State of Nevada. |